PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-2975

  1. 9,724 Posts.
    lightbulb Created with Sketch. 1234
    The wording used was actually "anticipated" . Given the 4-5 week delay at the start ("actual") I suspect we're on a similar timeline for last/final patient. From that point we have a short timeframe for final dosage of the final patient before they're in a position to do a preliminary read out. BTW I understand it was quite a demanding clinical process for those involved (twice a week and +1 hour a session). So a big thanks to those on here that put their hand up and endured the trial program.





 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.